Form 4: Molina Healthcare Director Acquires Stock Grant

Molina Healthcare Director Dale B. Wolf acquired 317 shares of common stock as part of his routine director compensation plan.

Summary

• Dale B. Wolf, a Director of Molina Healthcare, Inc. (MOH), acquired 317 shares of common stock.
• The transaction occurred on January 1, 2026, as a grant under the Issuer's 2025 Equity Incentive Plan.
• The shares were granted in connection with Mr. Wolf's services as a Director.
• The grant value for this quarter was $55,000, calculated based on the closing price of $173.54 per share on December 31, 2025, as January 1, 2026, was a non-trading day.
• Following this transaction, Mr. Wolf beneficially owns 14,991 shares, held indirectly by the Dale B. Wolf Revocable Trust.

Sentiment

Score: 6

Explanation: The filing reports a routine, pre-planned stock grant to a director, which is a positive for aligning interests but does not indicate significant new operational or financial developments.

Positives

• The stock grant aligns the director's financial interests with those of the shareholders, promoting long-term value creation.
• The transaction is part of a pre-approved equity incentive plan, indicating structured and transparent director compensation.

Future Outlook

The grant is part of the Issuer's 2025 Equity Incentive Plan, with an aggregate annual equity award of $220,000 for directors, implying future quarterly grants of $55,000 based on the closing price on the first day of each quarter.

Management Comments

• The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter.

Industry Context

This transaction represents a standard practice in corporate governance where public companies compensate their non-employee directors with equity to align their interests with long-term shareholder value. Such equity incentive plans are common across various industries, including healthcare.

Comparison to Industry Standards

• The use of equity grants as part of director compensation is a widely adopted practice across U.S. public companies, including those in the healthcare sector like Molina Healthcare.
• Many companies, such as UnitedHealth Group (UNH) and Anthem (ANTM), also utilize similar equity-based compensation structures for their non-executive directors to foster alignment with shareholder interests.
• The quarterly vesting schedule for director equity awards is a common mechanism to ensure ongoing commitment and retention, consistent with best practices observed in comparable large-cap healthcare providers.

Corporate Governance

Related Party Transactions

• The acquisition of common stock by Dale B. Wolf, a Director of Molina Healthcare, Inc., constitutes a related party transaction as it involves compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's interests with shareholders, potentially leading to decisions that enhance long-term shareholder value.
• Employees: No direct impact on employees is indicated by this specific filing.

Next Steps

• Future quarterly grants to directors are expected under the 2025 Equity Incentive Plan, with the next grant anticipated on the first day of the subsequent quarter.

Key Dates

Keywords

Molina Healthcare, MOH, Insider Transaction, Director Compensation, Stock Grant, Equity Incentive Plan, Form 4